Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia

J Atheroscler Thromb. 2023 Feb 1;30(2):203-205. doi: 10.5551/jat.LE003. Epub 2022 Jun 23.

Authors

Mariko Harada-Shiba^{1

2}, Ryo Koezuka³, Hisashi Makino³, Masatsune Ogura⁴

Affiliations

¹ Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute.
² Cardiovascular Center, Osaka Medical and Pharmaceutical University.
³ Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center.
⁴ Department of Metabolism and Endocrinology, Eastern Chiba Medical Center.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anticholesteremic Agents* / therapeutic use
Benzimidazoles / therapeutic use
Cholesterol, LDL
Homozygote
Homozygous Familial Hypercholesterolemia*
Humans
Hyperlipoproteinemia Type II* / drug therapy

Substances

BMS201038
Cholesterol, LDL
Benzimidazoles
Anticholesteremic Agents